KVUE:NYSE
Kenvue Inc
17,62 US$
arrow_downward
-0,48%(-0,085) 1 d
12 oct, 10:57:29 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de KVUE...
Abrir
17,66 US$
Alto
17,68 US$
Bajo
17,48 US$
Cap. burs.
33,83 mil M
Vol. medio
23,91 M
Volumen
3,53 M
Dividendo
4,77 %
Dividendo trimestral
0,21 US$
Fecha exdividendo
21 sept 2026
Ratio PER
20,42
Máximo en 52 sem.
20,13 US$
Mínimo en 52 sem.
14,02 US$
BPA
0,86 US$
Beta
0,48
Acciones en circulación
1920,77 M
N.º de empleados
22 mil
Abrir
17,66 US$
Alto
17,68 US$
Bajo
17,48 US$
Cap. burs.
33,83 mil M
Vol. medio
23,91 M
Volumen
3,53 M
Dividendo
4,77 %
Dividendo trimestral
0,21 US$
Fecha exdividendo
21 sept 2026
Ratio PER
20,42
Máximo en 52 sem.
20,13 US$
Mínimo en 52 sem.
14,02 US$
BPA
0,86 US$
Beta
0,48
Acciones en circulación
1920,77 M
N.º de empleados
22 mil
Noticias
De fuentes web y partners de noticias
Investing.com Nigeria
·
hace 1 día
Form 4 Kenvue Inc For: 11 October By Investing.com
Perfil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Acerca de Kenvue Inc
CEOKirk Perry
Empleados21,9 mil
Fundación2022
SedeSummit, Nueva Jersey, Estados Unidos
SectorPersonal care products
Sitio webkenvue.com